by [150+ Pages Report] As per the latest Research and survey report issued by Precedence Research, the global digital diabetes management market was valued at around USD 19.02 billion in 2021 and is expected to register revenues worth USD 90 billion by the end of 2030, growing at an exceptional CAGR of approximately 18.85% between 2022 and 2030.
Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1783
Digital Diabetes Management Market Report Scope
A recent study by Precedence Research on the digital diabetes management market offers a forecast for 2022 and 2030. The study analyzes crucial trends that are currently determining the growth of the digital diabetes management market. This report explicates on vital dynamics such as the drivers, restraints, and opportunities for key market players, along with key stakeholders as well as emerging players associated with the manufacturing of digital diabetes management. The study also provides the dynamics that are responsible for influencing the future status of the digital diabetes management market over the forecast period.
A detailed assessment of the digital diabetes management market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the digital diabetes management market along with their product portfolio enhances the reliability of this comprehensive research study.
Competition Landscape
The report has engulfed a chapter on the global digital diabetes management market’s competitive landscape, which provides detailed analysis and insights on companies offering digital diabetes management. Profiles of key companies, along with a strategic overview of their M&A and expansion plans across geographies, have been delivered in this chapter. This chapter is priceless for report readers, as its enables them in gauging their growth potential in the market and implement key strategies for extending their market reach.
This chapter offers key recommendations for both new and existing market participants, enabling them to emerge sustainably and profitably. Intelligence on the market players has been delivered on the basis of their product overview, SWOT analysis, key developments, key financials and company overview. Occupancy of these market participants has been tracked by the report and portrayed via an intensity map.
Read Also@ Carbon Dioxide Utilization Market Size to Worth Around US$ 7 Billion by 2030
Some of the Prominent Players in the Digital Diabetes Management Market Include:
- Bayer AG
- Medtronic
- Roche Diagnostics
- Dexcom Inc. LifeScan Inc.
- AgaMatrix
- One Drop
- Abbott Laboratories
- Ascensia Diabetes Care
- ARKRAY Inc
- ACON Laboratories
- Insulet Corporation
- B. Braun Melsungen AG
- Tandem Diabetes Care
- Dottli
- Ypsomed Holding AG
- Becton Dickinson and Company
- Glooko Inc.
- DarioHealth
- Care innovations
Digital Diabetes Management Market Segmentation
By Product
- Devices
- Smart Glucose Meters
- Continuous Glucose Monitoring (CGM) Systems
- Smart Insulin Pens
- Smart Insulin Pumps/Closed-loop Pumps & Smart Insulin Patches
- Application
- Diabetes & Blood Glucose Tracking Apps
- Obesity & Diet Management Apps
- Data Management Software & Platforms
- Services
- Apps
- Software
By Device Type
- Handheld Devices
- Wearable Devices
By Patient Type
- Type 1
- Type 2
By App
- Digital Diabetes Management Apps
- Weight & Diet Management Apps
By End-Use
- Hospitals
- Home Settings
- Diagnostic Centers & Clinics
Regional Segmentation
- Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
- Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
- North America [United States, Canada, Mexico]
- South America [Brazil, Argentina, Columbia, Chile, Peru]
- Middle East & Africa [GCC, North Africa, South Africa]
Regional Analysis
The research report includes a detailed study of regions of North America, Europe, China, Japan and Rest of the World. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2022 to 2030. These analyses will help the reader to understand the potential worth of investment in a particular region.
The report provides in-depth segment analysis of the global digital diabetes management market, thereby providing valuable insights at macro as well as micro levels. Analysis of major countries, which hold growth opportunities or account for significant share has also been included as part of geographic analysis of the digital diabetes management market.
The report includes country-wise and region-wise market size for the period 2022-2030. It also includes market size and forecast by segments in terms of production capacity, price and revenue for the period 2022-2030.
Why should you invest in this report?
If you are aiming to enter the global digital diabetes management market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for digital diabetes management are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Digital Diabetes Management Market
5.1. COVID-19 Landscape: Digital Diabetes Management Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Digital Diabetes Management Market, By Product
8.1. Digital Diabetes Management Market, by Product, 2022-2030
8.1.1. Devices
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Application
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Data Management Software & Platforms
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Services
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Digital Diabetes Management Market, By Device Type
9.1. Digital Diabetes Management Market, by Device Type, 2022-2030
9.1.1. Handheld Devices
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Wearable Devices
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Digital Diabetes Management Market, By Patient Type
10.1. Digital Diabetes Management Market, by Patient Type, 2022-2030
10.1.1. Type 1
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Type 2
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Digital Diabetes Management Market, By App
11.1. Digital Diabetes Management Market, by App, 2022-2030
11.1.1. Digital Diabetes Management Apps
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Weight & Diet Management Apps
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Digital Diabetes Management Market, By End-Use
12.1. Digital Diabetes Management Market, by End-Use, 2022-2030
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Home Settings
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Diagnostic Centers& Clinics
12.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Digital Diabetes Management Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.1.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.1.4. Market Revenue and Forecast, by App (2017-2030)
13.1.5. Market Revenue and Forecast, by End-Use (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.1.6.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.1.6.4. Market Revenue and Forecast, by App (2017-2030)
13.1.7. Market Revenue and Forecast, by End-Use (2017-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.8.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.1.8.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.1.8.4. Market Revenue and Forecast, by App (2017-2030)
13.1.8.5. Market Revenue and Forecast, by End-Use (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.2.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.2.4. Market Revenue and Forecast, by App (2017-2030)
13.2.5. Market Revenue and Forecast, by End-Use (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.6.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.2.6.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.2.7. Market Revenue and Forecast, by App (2017-2030)
13.2.8. Market Revenue and Forecast, by End-Use (2017-2030)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.2.10. Market Revenue and Forecast, by App (2017-2030)
13.2.11. Market Revenue and Forecast, by End-Use (2017-2030)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.12.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.2.12.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.2.12.4. Market Revenue and Forecast, by App (2017-2030)
13.2.13. Market Revenue and Forecast, by End-Use (2017-2030)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.14.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.2.14.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.2.14.4. Market Revenue and Forecast, by App (2017-2030)
13.2.15. Market Revenue and Forecast, by End-Use (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.3.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.3.4. Market Revenue and Forecast, by App (2017-2030)
13.3.5. Market Revenue and Forecast, by End-Use (2017-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.6.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.3.6.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.3.6.4. Market Revenue and Forecast, by App (2017-2030)
13.3.7. Market Revenue and Forecast, by End-Use (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.3.8.4. Market Revenue and Forecast, by App (2017-2030)
13.3.9. Market Revenue and Forecast, by End-Use (2017-2030)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.3.10.4. Market Revenue and Forecast, by App (2017-2030)
13.3.10.5. Market Revenue and Forecast, by End-Use (2017-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.11.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.3.11.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.3.11.4. Market Revenue and Forecast, by App (2017-2030)
13.3.11.5. Market Revenue and Forecast, by End-Use (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.4.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.4.4. Market Revenue and Forecast, by App (2017-2030)
13.4.5. Market Revenue and Forecast, by End-Use (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.4.6.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.4.6.4. Market Revenue and Forecast, by App (2017-2030)
13.4.7. Market Revenue and Forecast, by End-Use (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.4.8.4. Market Revenue and Forecast, by App (2017-2030)
13.4.9. Market Revenue and Forecast, by End-Use (2017-2030)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.4.10.4. Market Revenue and Forecast, by App (2017-2030)
13.4.10.5. Market Revenue and Forecast, by End-Use (2017-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.11.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.4.11.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.4.11.4. Market Revenue and Forecast, by App (2017-2030)
13.4.11.5. Market Revenue and Forecast, by End-Use (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.5.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.5.4. Market Revenue and Forecast, by App (2017-2030)
13.5.5. Market Revenue and Forecast, by End-Use (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.5.6.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.5.6.4. Market Revenue and Forecast, by App (2017-2030)
13.5.7. Market Revenue and Forecast, by End-Use (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Device Type (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Patient Type (2017-2030)
13.5.8.4. Market Revenue and Forecast, by App (2017-2030)
13.5.8.5. Market Revenue and Forecast, by End-Use (2017-2030)
Chapter 14. Company Profiles
14.1. Bayer AG
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Medtronic
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Roche Diagnostics
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Dexcom Inc. LifeScan Inc.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. AgaMatrix
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. One Drop
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Abbott Laboratories
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Ascensia Diabetes Care
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. ARKRAY Inc
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. ACON Laboratories
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1783
About Us
Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.
From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
